STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Why it matters: The **FDA's** updated 'breakthrough' device views will impact **device manufacturers** seeking expedited review.
- STAT+ subscribers gain exclusive access to an in-depth analysis of the FDA's changing perspective on 'breakthrough' device qualifications.
- April 1 marked the application deadline for the CMMI ACCESS Model's inaugural cohort, a key program for health technology.
- Health Tech newsletter readers are invited to share their experiences regarding the CMMI ACCESS Model application process, fostering community insight.
The article, exclusive to STAT+ subscribers, delves into the FDA's evolving criteria for 'breakthrough' device designations, a topic of significant interest for health tech innovators. It also notes the recent April 1 deadline for applications to the CMMI ACCESS Model's first cohort, indicating a busy period for health tech companies navigating regulatory and funding opportunities.
